New search | Conferencedetail
Print view
 
 

2nd Annual RNAi-Based Therapeutics Summit - June 2021 - Digital Event

Evvnt Promotion / evvnt
-
15.06.2021 - 17.06.2021  Virtual
Time: 9:00 am - 5:00 pm
 
Conference themes
As investments and collaborations hit a record high, the RNAi therapeutics industry continues to rapidly expand. With RNAi drugs prevailing as a therapy with huge potential against liver diseases, exciting efforts have now turned to a wide range of other diseases, from CNS, oncology, metabolism and more. Despite the growing momentum, much needs to be addressed in terms of targeted delivery, safety, and efficiency to fully unleash the therapeutic value of RNAi drugs.
Professional congress organizer (PCO)
Hanson Wade
Notes
Speakers: Greg Hinkle Vice President, Research Informatics Alnylam Pharmaceuticals, Ekkehard Leberer Senior Director, R&D Alliance Management Sanofi, Julia Alterman Senior Scientist Khvorova Lab University of Massachusetts Medical School and more
 

Enquiries and Registration:

https://go.evvnt.com/733422-0?pid=4832
Mr. Customer Service
 
Categories
General Medicine, Public Health
Languages
English
Congress fees
Conference Only: USD 1999.00, Conference + 1 Workshop: USD 2348.00, Conference + 2 Workshops: USD 2697.00
Participants expected
1000
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

AMREF - African Medical and Research FoundationOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation European Public Health Association (EUPHA)Centro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioCharité International AcademyAnästhesie in Entwicklungsländern e. V.Center of ExcellenceÖsterreichisches Rotes Kreuz